Tech Company Financing Transactions

KalGene Pharmaceuticals Funding Round

KalGene Pharmaceuticals, based in Toronto ON, secured funding from Lumira Capital , Accel-Rx Health Sciences Accelerator and Anges Quebec.

Transaction Overview

Announced On
11/28/2017
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors

Lumira Capital (Lead Investor) (Daniel Hetu)

Accel-Rx Health Sciences Accelerator (Natalie Dakers)

Anges Quebec (François Gilbert)

Proceeds Purpose
Proceeds from these combined funding sources will support the development of KalGene's lead Alzheimer's therapeutic candidate.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Toronto ON, M3C
Canada
Email Address
Overview
Preventing Alzheimer's disease progression remains a critical unmet need for millions of people worldwide. Today, nearly 44 million people have or are living with an Alzheimer's related disease worldwide.
Profile
KalGene Pharmaceuticals LinkedIn Company Profile
Social Media
KalGene Pharmaceuticals Company Twitter Account
Company News
KalGene Pharmaceuticals News
Facebook
KalGene Pharmaceuticals on Facebook
YouTube
KalGene Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Sena Biswas
  Sena Biswas LinkedIn Profile  Sena Biswas Twitter Account  Sena Biswas News  Sena Biswas on Facebook
President
Nathan Yoganathan
  Nathan Yoganathan LinkedIn Profile  Nathan Yoganathan Twitter Account  Nathan Yoganathan News  Nathan Yoganathan on Facebook
VP - Product Management
John Gillard
  John Gillard LinkedIn Profile  John Gillard Twitter Account  John Gillard News  John Gillard on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/27/2017: HydroEdge Solutions venture capital transaction
Next: 11/28/2017: Libra venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary